↓ 跳过正文

Nonpharmaceutical Interventions

Voluntary Compliance with COVID-19 Nonpharmaceutical Interventions: Evidence from Mainland China and Hong Kong

JCC — pp. 1-21 2026-09-23 Original Voluntary Compliance with COVID-19 Nonpharmaceutical Interventions: Evidence from Mainland China and Hong Kong Elvis H. Kim Abstract In response to COVID-19 outbreaks, China implemented aggressive and comprehensive nonpharmaceutical interventions (NPIs), whose epidemiological effectiveness is often attributed to government coercion. However, sustained compliance also relies on a broad consensus regarding the nature of the disease and the legitimacy of interventions. Drawing on surveys conducted immediately before reopening in mainland China and Hong Kong, this study examines the foundations of voluntary compliance. The findings show that beyond coercion, both instrumental and normative concerns affect compliance. Perceived severity of COVID-19, perceived effectiveness of NPIs, collectivist orientation, and institutional trust are associated with higher voluntary compliance, whereas negative impacts of NPIs, especially psychological burdens, are associated with lower voluntary compliance. These results highlight the importance of legitimacy and consensus mobilization in sustaining compliance.